AU1276399A - Neuronal uses of bmp-11 - Google Patents

Neuronal uses of bmp-11

Info

Publication number
AU1276399A
AU1276399A AU12763/99A AU1276399A AU1276399A AU 1276399 A AU1276399 A AU 1276399A AU 12763/99 A AU12763/99 A AU 12763/99A AU 1276399 A AU1276399 A AU 1276399A AU 1276399 A AU1276399 A AU 1276399A
Authority
AU
Australia
Prior art keywords
proteins
bmp
neuronal
useful
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU12763/99A
Other languages
English (en)
Inventor
Anthony J. Celeste
Scott R Thies
John M. Wozney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU1276399A publication Critical patent/AU1276399A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12763/99A 1997-11-07 1998-10-23 Neuronal uses of bmp-11 Withdrawn AU1276399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96629797A 1997-11-07 1997-11-07
US08966297 1997-11-07
PCT/US1998/022574 WO1999024057A2 (en) 1997-11-07 1998-10-23 Neuronal uses of bmp-11

Publications (1)

Publication Number Publication Date
AU1276399A true AU1276399A (en) 1999-05-31

Family

ID=25511184

Family Applications (2)

Application Number Title Priority Date Filing Date
AU12763/99A Withdrawn AU1276399A (en) 1997-11-07 1998-10-23 Neuronal uses of bmp-11
AU13900/99A Ceased AU761940B2 (en) 1997-07-29 1998-11-06 Neuronal uses of BMP-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU13900/99A Ceased AU761940B2 (en) 1997-07-29 1998-11-06 Neuronal uses of BMP-11

Country Status (10)

Country Link
EP (1) EP1028744B1 (https=)
JP (1) JP2001522810A (https=)
AT (1) ATE259652T1 (https=)
AU (2) AU1276399A (https=)
CA (1) CA2309538A1 (https=)
DE (1) DE69821793T2 (https=)
DK (1) DK1028744T3 (https=)
ES (1) ES2213927T3 (https=)
PT (1) PT1028744E (https=)
WO (2) WO1999024057A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104977A1 (en) * 2000-03-31 2003-06-05 Ugo Ripamonti Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
TWI329129B (en) * 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US20040259779A1 (en) * 2001-07-06 2004-12-23 Teit Johansen Novel neurotrophic factors
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
BR0307871A (pt) 2002-02-21 2005-04-12 Wyeth Corp Proteìnas contendo domìnio de folistatina
CA2476887A1 (en) 2002-02-21 2003-09-04 Wyeth Gasp1:a follistatin domain containing protein
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
CA2518102C (en) 2003-03-04 2009-05-12 Tanabe Seiyaku Co., Ltd. Powdery preparation for nasal administration
BRPI0410927A (pt) 2003-06-02 2006-06-27 Wyeth Corp métodos terapêuticos e profiláticos para distúrbios neuromusculares
BRPI0616923A2 (pt) 2005-10-06 2011-07-05 Lilly Co Eli anticorpos monoclonais, seus usos e composição farmacêutica
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
CA2661836A1 (en) 2006-09-05 2008-03-13 Eli Lilly And Company Anti-myostatin antibodies
EP2983694B1 (en) 2013-04-08 2022-06-22 President and Fellows of Harvard College Compositions for rejuvenating skeletal muscle stem cells
EP3881859B1 (en) * 2013-06-11 2024-03-06 President and Fellows of Harvard College Compositions for increasing neurogenesis and angiogenesis
WO2015070076A2 (en) * 2013-11-08 2015-05-14 President And Fellows Of Harvard College Methods and compositions for rejuvenating neuromuscular junctions
CA3010799A1 (en) 2016-01-06 2017-07-13 President And Fellows Of Harvard College Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis
WO2019144053A1 (en) * 2018-01-19 2019-07-25 President And Fellows Of Harward College Gdf11 variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9406715A (pt) * 1993-05-12 1996-02-06 Genetics Inst Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-11) polipeptideo de proteina-11 morfogenética de osso purificada (BMP-11) e molécula de DNA quimérica
SE9302550D0 (sv) * 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
DK0716610T3 (da) * 1993-08-26 2006-09-04 Genetics Inst Llc Humane knogle-morfogenetiske proteiner til anvendelse ved neural regenerering
CA2194660C (en) * 1994-07-08 2009-09-29 Se-Jin Lee Growth differentiation factor-11

Also Published As

Publication number Publication date
DE69821793D1 (de) 2004-03-25
EP1028744A2 (en) 2000-08-23
JP2001522810A (ja) 2001-11-20
CA2309538A1 (en) 1999-05-20
AU1390099A (en) 1999-05-31
EP1028744B1 (en) 2004-02-18
WO1999024058A2 (en) 1999-05-20
ES2213927T3 (es) 2004-09-01
PT1028744E (pt) 2004-06-30
DK1028744T3 (da) 2004-06-21
WO1999024058A3 (en) 1999-08-19
ATE259652T1 (de) 2004-03-15
AU761940B2 (en) 2003-06-12
WO1999024057A2 (en) 1999-05-20
DE69821793T2 (de) 2004-12-30

Similar Documents

Publication Publication Date Title
CA2161808A1 (en) Bmp-11 compositions
AU1276399A (en) Neuronal uses of bmp-11
ATE265529T1 (de) Bmp-10 zusammensetzungen
CA2030518A1 (en) Osteoinductive compositions
AU2817095A (en) Bmp-9 compositions
IL112873A0 (en) Rapamycin-fkbp12 binding proteins their isolation and their use
AU4165797A (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
EP1719531A3 (en) Osteogenic devices and methods of use thereof for repair of bones
NZ510356A (en) Molecules designated LDCAM
EP1420031A3 (en) Bone morphogenetic protein (BMP)-18 compositions
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
GB2367061A (en) Peptides
IL125771A0 (en) Recombinant ribonuclease proteins
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
GB2374871A (en) Peptide fragments of colostrinin and their use
MXPA02000801A (es) Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.
MX9800507A (es) Ctla-8 humana y usos de proteinas relacionadas con la ctla-8.
UA32147A (uk) Спосіб профілактики вторинних деформацій носа при вроджених та набутих незрощеннях верхньої губи
AU5246598A (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis